Quote from above:
Once again, Johnson & Johnson is running low on a product due to a manufacturing issue. This time, the Nizoral anti-fungal shampoo - the only over-the-counter shampoo that is a salve for dandruff and psoriasis - has been out of stock for weeks and the health care giant is blaming a switch in manufacturing facilities that will keep supplies diminished for the rest of the year.
As someone who works retail OTC, I've got to agree with the conclusions drawn in the above article about J&J's damaged reputation in the eyes of both consumers and retailers. Most of their OTC medicines are still
difficult to get (and they've pretty much given the pediatrics market to the competition) two years after the initial recalls began happening, they managed to damage their Neosporin and Band-Aid brands with long shortages earlier this year, they hurt their tampon business with months-long manufacturing-related shortages.